These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 10826517)
1. Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy. Freyberger H; Bröcker M; Yakut H; Hammer J; Effert R; Schifferdecker E; Schatz H; Derwahl M Exp Clin Endocrinol Diabetes; 2000; 108(2):106-9. PubMed ID: 10826517 [TBL] [Abstract][Full Text] [Related]
2. Vitreous and serum levels of platelet-derived growth factor and their correlation in patients with proliferative diabetic retinopathy. Praidou A; Klangas I; Papakonstantinou E; Androudi S; Georgiadis N; Karakiulakis G; Dimitrakos S Curr Eye Res; 2009 Feb; 34(2):152-61. PubMed ID: 19219687 [TBL] [Abstract][Full Text] [Related]
3. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689 [TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954 [TBL] [Abstract][Full Text] [Related]
5. [Cytokines in the vitreous fluid of patients with proliferative diabetic retinopathy--vascular endothelial growth factor and platelet-derived growth factor are elevated in proliferative diabetic retinopathy]. Endo H; Naito T; Asahara T; Kajima M; Shiota H Nippon Ganka Gakkai Zasshi; 2000 Oct; 104(10):711-6. PubMed ID: 11081306 [TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212 [TBL] [Abstract][Full Text] [Related]
7. Vitreous and serum levels of vascular endothelial growth factor and platelet-derived growth factor and their correlation in patients with non-proliferative diabetic retinopathy and clinically significant macula oedema. Praidou A; Papakonstantinou E; Androudi S; Georgiadis N; Karakiulakis G; Dimitrakos S Acta Ophthalmol; 2011 May; 89(3):248-54. PubMed ID: 19799585 [TBL] [Abstract][Full Text] [Related]
8. [TNF-alpha level in the vitreous body. Increase in neovascular eye diseases and proliferative diabetic retinopathy]. Spranger J; Meyer-Schwickerath R; Klein M; Schatz H; Pfeiffer A Med Klin (Munich); 1995 Mar; 90(3):134-7. PubMed ID: 7723714 [TBL] [Abstract][Full Text] [Related]
9. Deficient activation and different expression of transforming growth factor-beta isoforms in active proliferative diabetic retinopathy and neovascular eye disease. Spranger J; Meyer-Schwickerath R; Klein M; Schatz H; Pfeiffer A Exp Clin Endocrinol Diabetes; 1999; 107(1):21-8. PubMed ID: 10077351 [TBL] [Abstract][Full Text] [Related]
10. Decreased angiogenin concentration in vitreous and serum in proliferative diabetic retinopathy. Marek N; Raczyńska K; Siebert J; Myśliwiec M; Zorena K; Myśliwska J; Reiwer-Gostomska M; Trzonkowski P Microvasc Res; 2011 Jul; 82(1):1-5. PubMed ID: 21539846 [TBL] [Abstract][Full Text] [Related]
11. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy. Mohan N; Monickaraj F; Balasubramanyam M; Rema M; Mohan V J Diabetes Complications; 2012; 26(5):435-41. PubMed ID: 22699109 [TBL] [Abstract][Full Text] [Related]
12. Vitreous Levels of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Patients with Proliferative Diabetic Retinopathy: A Clinical Correlation. Al-Dwairi R; El-Elimat T; Aleshawi A; Al Sharie AH; Abu Mousa BM; Al Beiruti S; Alkazaleh A; Mohidat H Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002312 [No Abstract] [Full Text] [Related]
13. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy. Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666 [TBL] [Abstract][Full Text] [Related]
14. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study. Simó R; Hernández C; Segura RM; García-Arumí J; Sararols L; Burgos R; Cantón A; Mesa J Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576 [TBL] [Abstract][Full Text] [Related]
15. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056 [TBL] [Abstract][Full Text] [Related]
16. [Significance and detection of insulin-like growth factor I in vitreous with proliferative retinal diseases by radioimmunoassay]. Cao J; Wu L; Zhang H Zhonghua Yan Ke Za Zhi; 1995 Mar; 31(2):122-5. PubMed ID: 7656720 [TBL] [Abstract][Full Text] [Related]
17. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858 [TBL] [Abstract][Full Text] [Related]
18. Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation? Spranger J; Möhlig M; Osterhoff M; Bühnen J; Blum WF; Pfeiffer AF Horm Metab Res; 2001 May; 33(5):312-6. PubMed ID: 11440279 [TBL] [Abstract][Full Text] [Related]
19. High vitreous concentration of vascular endothelial growth factor in diabetic patients with proliferative retinopathy using statins. Liinamaa MJ; Savolainen MJ Ann Med; 2008; 40(3):209-14. PubMed ID: 18382886 [TBL] [Abstract][Full Text] [Related]
20. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy. Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]